Yes, semaglutide medication, like Ozempic, Wegovy, and Rybelsus, can cause vision loss. More specifically, it can cause non-arteritic anterior ischemic optic neuropathy (NAION). Some of the side effects of semaglutide are nausea, vomiting, and dehydration, which causes reduced blood volume, which eventually leads to weak blood flow to the optic nerve, causing damage and resulting in NAION.
People who’ve undergone semaglutide treatment for weight management or type 2 diabetes are prone to not just vision loss but also gastroparesis and bowel obstruction. There are over 1,300 cases against semaglutide manufacturers, and you could be a potential claimant as well.
Some of the people who’ve been treated with Ozempic, Wegovy, and Rybelsus are now suffering from vision loss, bowel obstruction, and gastroparesis. If you’re one of them, you could have a case against manufacturers of semaglutide. Don’t hesitate to reach out to our team, and we’ll see if you have a case against Novo Nordisk. If the case is eligible for a claim, we’ll put you in touch with an attorney who specializes in cases like this.